Internet Stroke Center Home Stroke Trials Registry
 
National Institute of Neurological Disorders & Stroke
American Stroke Association
Washington University School of Medicine
 
 Trials Directories
Ongoing Trials
Completed Trials
Acute Stroke Trials
Hemorrhage Trials
Prevention Trials
Recovery Trials
 Interventions
Drugs - By Name
Drugs - By Category
Procedures
Recovery Therapies
 Assessment Scales
Specific Stroke Scales
Stroke Scales Overview
 Stroke Trial Links
Government Sites
Independent Sites
 News & Updates
Update List
General Stroke News
About this Site
Submit Your Trial
Send Feedback

 Search for Trials

PubMed
We comply with the "Health on the Net" (HON) code of standards for trustworthy health information: verify here.



 
Stroke Interventions in Clinical Trials
Printable Version
Clomethiazole
Zendra®

Action
GABA agonist

Status
Phase II trial (CLASS) results published 1999. Phase III trials CLASS-I, CLASS-H, CLASS-T) completed 2000. Development of clomethiazole halted 11/00 when CLASS-I trial showed no effect in patients with ischemic stroke.

Trial(s)
  = Ongoing
  = Completed

CLASS Clomethiazole Acute Stroke Study
CLASS-IHT Clomethiazole Acute Stroke Study in Ischemic, Hemorrhagic, and tPA-treated Patients

Web Links and Publications
AstraZeneca Web Site.

The Clomethiazole Acute Stroke Study in tissue-type plasminogen activator-treated stroke (CLASS-T): final results.
Neurology. 2001 Oct 9;57(7):1199-205.

Results in 95 hemorrhagic stroke patients included in CLASS, a controlled trial of clomethiazole versus placebo in acute stroke patients.
Stroke 2000 Jan;31(1):82-5.

Clomethiazole (Zendra) in acute ischemic stroke: basic pharmacology and biochemistry and clinical efficacy.
Pharmacol Ther 1998 Nov;80(2):123-47

UID: 11

   

Internet Stroke Center at Washington University:
HOME | ABOUT | PRIVACY POLICY | CONTACT

Copyright © 1997-2009 - Internet Stroke Center. All rights reserved.                                           Last modified: Friday, November 20, 2009